Neuronal nicotinic receptor agonists ameliorate spontaneous motor asymmetries and motor discoordination in a unilateral mouse model of Parkinson's disease

2013 ◽  
Vol 111 ◽  
pp. 1-10 ◽  
Author(s):  
Aaron Kucinski ◽  
Scott Wersinger ◽  
Ewa K. Stachowiak ◽  
Thomas D. Corso ◽  
Matthew J. Parry ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Mouse Model ◽  
Nicotinic Receptor ◽  
Neuronal Nicotinic Receptor ◽  
Receptor Agonists ◽  
Motor Asymmetries

scholarly journals Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease

2018 ◽  
Vol 133 ◽  
pp. 385-394 ◽  
Author(s):  
Peng Feng ◽  
Xiangjian Zhang ◽  
Dongfang Li ◽  
Chenhui Ji ◽  
Ziyue Yuan ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Mouse Model ◽  
Receptor Agonists ◽  
Gip Receptor

scholarly journals Nicotinic Receptor Agonists Reduce l-DOPA–Induced Dyskinesias in a Monkey Model of Parkinson's Disease

2013 ◽  
Vol 347 (1) ◽  
pp. 225-234 ◽  
Author(s):  
Danhui Zhang ◽  
Archana Mallela ◽  
David Sohn ◽  
F. Ivy Carroll ◽  
Merouane Bencherif ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Nicotinic Receptor ◽  
Receptor Agonists ◽  
Monkey Model

Repurposing GLP-1 Receptor Agonists for Parkinson’s Disease: Current Evidence and Future Opportunities

2021 ◽  
Author(s):  
Daniella Balduino Victorino ◽  
Mariana Nejm ◽  
Marcia Guimarães-Marques ◽  
Fulvio Alexandre Scorza ◽  
Carla Alessandra Scorza
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Current Evidence ◽  
Receptor Agonists
Sign in / Sign up

Export Citation Format

Share Document